Commonwealth Equity Services’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$188K Buy
53,626
+2,127
+4% +$6.8K ﹤0.01% 4024
2025
Q4
$141K Sell
51,499
-151
-0.3% -$349 ﹤0.01% 4063
2025
Q3
$112K Sell
51,650
-2,043
-4% -$4.82K ﹤0.01% 4069
2025
Q2
$92K Sell
53,693
-1,765
-3% -$4.39K ﹤0.01% 4077
2025
Q1
$185K Buy
55,458
+23,944
+76% +$123K ﹤0.01% 3868
2024
Q4
$233K Buy
31,514
+16,113
+105% +$149K ﹤0.01% 3632
2024
Q3
$145K Buy
15,401
+1,996
+15% +$18.9K ﹤0.01% 3801
2024
Q2
$108K Buy
13,405
+3,133
+31% +$33.6K ﹤0.01% 3796
2024
Q1
$152K Buy
+10,272
New +$120K ﹤0.01% 3706
2021
Q4
Sell
-9,491
Closed -$234K 3692
2021
Q3
$234K Sell
9,491
-511
-5% -$12K ﹤0.01% 3145
2021
Q2
$260K Buy
10,002
+2,992
+43% +$77.8K ﹤0.01% 3038
2021
Q1
$221K Buy
7,010
+1,565
+29% +$64.9K ﹤0.01% 3054
2020
Q4
$252K Buy
+5,445
New +$216K ﹤0.01% 2724

Other funds holding IOVA